ICRP 123: Ar40 - dawki narządowe i współczynniki jakości
Źródło: ICRP Publication 123, Assessment of Radiation Exposure of Astronauts in Space, supplementary data, Annals of the ICRP 42(4), 2013, strony PDF: arkusz Ar40. Podpis w źródle: Supplementary data workbook P 123 JAICRP 42(4) DB of heavy ion.xls, sheet Ar40
Znormalizowana macierz danych ICRP 123 dla cząstki Ar40: energia, narząd lub wielkość efektywna, płeć fantomu, typ wielkości, jednostka i wartość. Dane obejmują współczynniki konwersji fluencji cząstek na dawkę pochłoniętą oraz średnie współczynniki jakości w geometrii izotropowej.
Źródłowe arkusze miały układ szeroki z wielopoziomowymi nagłówkami; import zapisano w układzie długim, aby można było filtrować po energii, narządzie, płci i typie wielkości.
Kolumny SwTDT/F, DT/F, QICRP60 i QNASA zachowują nazwy źródłowe z arkusza. Jednostka pGy cm2 lub pSv cm2 jest podana w kolumnie jednostka wartości.
Pokazano 4392 z 4392 wierszy.
| Cząstka | Symbol | Z | A | Energia | Jednostka energii | Narząd/tkanka albo wielkość | Płeć/fantom | Wielkość źródłowa | Opis wielkości | Jednostka wartości | Wartość |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 70.5 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 63.7 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 77.3 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6370 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7730 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 1 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 141 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 127 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 155 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12700 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15500 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 2 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 211 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 191 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 231 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19100 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23100 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 3 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 351 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 317 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 385 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31700 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38500 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 5 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 814 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 780 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 847 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.32 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.21 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 693 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 864 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.12 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.68 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63000 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76200 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.3 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.35 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 773 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.5 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.8 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.17 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 10 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1160 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1110 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1200 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.1 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.51 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.119 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.115 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.123 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.13 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.128 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.122 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.123 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.128 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.316 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.18 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34.1 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.55 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.155 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.163 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12.2 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.213 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87600 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11.5 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.117 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.111 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.109 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.9 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.161 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.1 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.19 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.117 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.163 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0975 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.115 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.113 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.141 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.136 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.242 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.95 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.95 |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 14 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1680 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1640 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1730 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16.7 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.79 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2110 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2000 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.475 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.482 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.473 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.494 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.379 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.498 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1700 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.273 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.443 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.466 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.338 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.427 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.535 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.737 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.413 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.612 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.1 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12.3 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.585 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.61 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32.6 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.14 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 148000 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24.3 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.416 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.449 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1850 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 297 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.48 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.381 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.428 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.458 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.416 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.455 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.707 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.78 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.502 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.37 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.358 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.435 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.379 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.497 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.441 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.431 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.381 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.46 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.77 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14 |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2660 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2650 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2660 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29.8 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.9 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4850 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4330 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.69 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.63 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.63 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.69 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.51 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.73 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2970 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.68 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.49 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.6 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.55 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.5 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.2 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.05 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.63 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.85 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90.9 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22.6 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.06 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.33 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.2 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.37 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 180000 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 213000 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 257 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.5 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.14 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.42 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2920 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 465 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.36 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.26 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.46 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.58 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.37 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.4 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 211 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.36 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 196 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.34 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12.3 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.36 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.33 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.16 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.33 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.49 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.52 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.49 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.58 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.73 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.64 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.2 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.2 |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 30 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 5240 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 5610 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 4870 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.9 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32.7 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20600 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18600 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.41 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.93 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.99 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.9 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.84 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.64 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6680 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.51 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.06 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.5 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.06 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.9 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21.9 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.63 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.1 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 217 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.3 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15.6 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 792 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.6 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 250000 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 261000 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 597 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.8 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.1 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.8 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6360 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.5 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.05 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.45 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.21 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.64 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.95 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 848 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.9 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13.8 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.4 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.92 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.78 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.13 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.14 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.48 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.76 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.36 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.08 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.4 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15.9 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46500 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46500 |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 10400 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 12400 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 8440 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 247 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 161 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71700 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51800 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.9 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.9 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.5 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.3 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31.4 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.4 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16200 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15.3 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31.6 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.9 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 27.8 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31.3 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.9 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24.9 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.6 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 623 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 296 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.6 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.5 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9460 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 846 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 210000 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 213000 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.1 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1710 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 331 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.7 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14800 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2610 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22.8 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19.5 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28.7 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35.1 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22.9 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25.1 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5150 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 168 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1990 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 783 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14.5 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21.3 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15.9 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.3 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28.1 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30.4 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.4 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.9 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 230000 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.3 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 230000 |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ar40 | Ar-40 | 18 | 40 | 75 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 15600 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 19600 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 11700 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 885 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78200 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 175 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 131 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 155 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.7 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29500 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.2 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.5 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.6 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 306 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 328 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84.4 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2510 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2440 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 210 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 247 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32900 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10600 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177000 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 175000 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3940 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29100 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9090 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.7 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.1 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.7 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.5 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11800 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1560 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7720 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2460 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3850 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41.7 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.4 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.5 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.7 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.7 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 797 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 345 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 199000 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 199000 |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 26200 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 31700 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 20600 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11100 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10800 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 176000 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.8 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 959 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 764 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 787 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 452 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 882 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56100 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 316 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 942 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 831 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 626 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16700 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24800 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 391 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23600 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25600 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22100 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2080 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5130 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79600 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46600 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138000 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 25.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139000 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 25.8 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10700 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7200 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 349 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 362 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57600 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.7 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31500 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 360 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 378 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 390 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 436 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24900 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18300 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31900 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16000 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16600 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 272 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 426 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 295 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 321 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 456 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 466 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11600 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7560 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.4 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ar40 | Ar-40 | 18 | 40 | 150 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.4 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 34300 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 37800 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 30800 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20800 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21200 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 158000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9530 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10600 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6080 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6340 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2150 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12200 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76600 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 967 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6060 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9010 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5520 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4690 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58400 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38600 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51400 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23600 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37600 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77800 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 26.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 26.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75400 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44200 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1950 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2460 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4370 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33400 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29700 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57100 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42100 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18600 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.4 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32500 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 841 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 872 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3090 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2790 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1340 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4050 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37200 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34600 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.1 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 200 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 58300 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.8 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 58400 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 58200 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43600 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46300 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.8 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 25.4 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.4 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 25 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51100 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56200 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47900 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.7 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67900 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38300 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53200 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3660 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35400 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48400 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.8 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22900 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28300 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84100 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68700 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.4 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29800 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.4 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88300 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.7 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89700 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86800 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.4 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97400 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.8 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42500 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43400 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19300 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11400 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.8 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90800 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75700 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16100 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8850 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31600 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.7 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40500 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21500 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21400 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47500 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.2 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49500 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90700 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.2 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88700 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90500 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3040 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3470 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5580 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34100 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41500 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56200 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71100 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62700 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.5 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.3 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24 | |
| Ar40 | Ar-40 | 18 | 40 | 300 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 96100 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 91100 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 101000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88700 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99700 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 25.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81100 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94400 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83800 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95300 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91600 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76400 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78500 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 25.1 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 25 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88400 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99200 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68600 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91200 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75500 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91100 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93500 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78200 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94800 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90500 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.1 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76800 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88800 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75700 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82400 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86300 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95400 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92100 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.7 | |
| Ar40 | Ar-40 | 18 | 40 | 500 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 93200 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 92600 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 93800 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88900 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87400 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89200 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95200 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95800 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89800 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95900 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81600 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.4 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93700 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95700 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99900 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86700 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.4 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87200 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94700 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98300 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89700 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91900 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80500 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91700 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98400 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83400 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84500 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92200 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94100 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83600 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88600 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91400 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93600 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93900 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95100 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95900 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99500 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80200 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88800 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90500 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87600 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85700 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89100 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88800 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94400 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89900 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ar40 | Ar-40 | 18 | 40 | 700 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 74500 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 73600 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 75400 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70300 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72700 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89200 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86100 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69500 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71000 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73600 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77500 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68400 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75700 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77800 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64700 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68300 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72200 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68900 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76000 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76600 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82500 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64900 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74000 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78000 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78100 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82300 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83200 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80100 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84800 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88100 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88700 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69900 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73000 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68200 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64100 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83600 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82200 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66800 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68100 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67800 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73900 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65300 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71700 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73200 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74200 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77500 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77300 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76600 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82700 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61900 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68200 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63700 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66200 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66600 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69400 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65300 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71800 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72600 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78700 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88600 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88600 |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Ar40 | Ar-40 | 18 | 40 | 1000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 61300 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 60800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 61900 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59200 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76400 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74400 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56300 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59500 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63600 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56700 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60000 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61100 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52300 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55400 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58900 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52500 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59700 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63300 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53200 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61900 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64900 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67100 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71000 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69400 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78100 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58000 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59300 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53000 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67500 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65700 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57900 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57900 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58200 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55200 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60900 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59700 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65600 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65100 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65800 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65000 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49500 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55000 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51100 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53500 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54600 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57600 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54000 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61200 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64900 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62900 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80300 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80300 |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 2000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 62300 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 61800 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 62700 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59900 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57800 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64800 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56900 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60500 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60200 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62800 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63900 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54900 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58700 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69300 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70800 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71500 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72600 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78200 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78800 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59500 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61200 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55500 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56800 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72200 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67800 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57600 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63600 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53300 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57600 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60500 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61300 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67200 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66300 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68300 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68600 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50500 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58300 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56200 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56100 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61000 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64700 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63900 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78400 |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Ar40 | Ar-40 | 18 | 40 | 3000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 68400 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 67600 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 69300 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65700 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68200 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76000 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81900 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66000 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67400 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67700 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72700 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62300 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65400 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71700 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56500 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65400 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65400 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67700 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69500 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70900 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73100 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60100 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64800 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71500 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75300 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73800 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77900 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75500 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74100 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82700 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84300 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64300 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66900 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63000 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59000 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75300 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75900 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61900 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58600 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63300 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69000 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61400 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68000 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67500 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69700 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72500 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72500 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72400 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75400 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55100 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63700 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56400 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58000 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64200 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67500 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62000 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63100 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61600 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70100 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78800 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78800 |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Ar40 | Ar-40 | 18 | 40 | 5000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 68400 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 68100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 68700 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66700 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77900 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69200 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60500 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61900 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65000 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69500 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62900 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70300 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65400 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73000 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72900 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77800 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79000 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73700 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84500 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84800 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65500 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63000 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73900 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63300 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66300 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65100 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67800 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67300 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73300 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73000 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73700 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72800 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57500 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61300 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56500 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62200 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65900 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64000 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66000 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70600 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70700 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77900 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77900 |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ar40 | Ar-40 | 18 | 40 | 10000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 78500 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 78700 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 78300 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77000 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77400 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78900 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82000 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79500 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72200 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74000 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77500 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73000 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77700 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73500 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78300 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82600 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84400 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79900 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80900 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85700 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92400 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75500 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76000 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68700 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87300 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74500 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71900 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73200 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79200 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78400 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82000 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82200 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81000 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70400 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70700 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72400 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77300 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73200 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74600 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78100 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79800 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97600 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97600 |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ar40 | Ar-40 | 18 | 40 | 20000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 95900 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 96500 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 95300 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97700 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95900 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93700 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95700 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98300 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98700 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88500 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93500 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94100 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94800 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92400 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90700 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91900 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91300 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94200 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93600 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98500 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99200 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92600 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97500 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97500 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95100 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94100 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91700 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91500 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95300 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96400 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91900 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87500 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89100 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91400 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91600 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97400 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90100 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96400 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92900 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96900 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87700 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88700 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92400 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89100 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94300 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94100 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94000 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96900 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90100 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90900 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90900 |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ar40 | Ar-40 | 18 | 40 | 50000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 114000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 115000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 112000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.1 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ar40 | Ar-40 | 18 | 40 | 100000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 |